Pacira BioSciences Statistics Share Statistics Pacira BioSciences has 44.93M
shares outstanding. The number of shares has increased by -2.69%
in one year.
Shares Outstanding 44.93M Shares Change (YoY) -2.69% Shares Change (QoQ) -2.96% Owned by Institutions (%) 99.99% Shares Floating 39.82M Failed to Deliver (FTD) Shares 42 FTD / Avg. Volume 0.01%
Short Selling Information The latest short interest is 6.69M, so 14.88% of the outstanding
shares have been sold short.
Short Interest 6.69M Short % of Shares Out 14.88% Short % of Float 21.34% Short Ratio (days to cover) 10.33
Valuation Ratios The PE ratio is -8.75 and the forward
PE ratio is 7.54.
Pacira BioSciences's PEG ratio is
0.03.
PE Ratio -8.75 Forward PE 7.54 PS Ratio 1.24 Forward PS 1.4 PB Ratio 1.12 P/FCF Ratio 4.87 PEG Ratio 0.03
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Pacira BioSciences.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 2.4,
with a Debt / Equity ratio of 0.82.
Current Ratio 2.4 Quick Ratio 2 Debt / Equity 0.82 Debt / EBITDA 21.94 Debt / FCF 3.57 Interest Coverage -4.43
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $889.55K Profits Per Employee $-126.35K Employee Count 788 Asset Turnover 0.45 Inventory Turnover 1.36
Taxes Income Tax 36.45M Effective Tax Rate -57.77%
Stock Price Statistics The stock price has increased by 50.36% in the
last 52 weeks. The beta is 0.41, so Pacira BioSciences's
price volatility has been higher than the market average.
Beta 0.41 52-Week Price Change 50.36% 50-Day Moving Average 25.19 200-Day Moving Average 24.3 Relative Strength Index (RSI) 40.6 Average Volume (20 Days) 648,914
Income Statement In the last 12 months, Pacira BioSciences had revenue of 700.97M
and earned -99.56M
in profits. Earnings per share was -2.15.
Revenue 700.97M Gross Profit 530.54M Operating Income -73.37M Net Income -99.56M EBITDA 29.12M EBIT -49.67M Earnings Per Share (EPS) -2.15
Full Income Statement Balance Sheet The company has 276.77M in cash and 638.85M in
debt, giving a net cash position of -362.08M.
Cash & Cash Equivalents 276.77M Total Debt 638.85M Net Cash -362.08M Retained Earnings -206.36M Total Assets 1.54B Working Capital 432.45M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was 189.39M
and capital expenditures -10.64M, giving a free cash flow of 178.75M.
Operating Cash Flow 189.39M Capital Expenditures -10.64M Free Cash Flow 178.75M FCF Per Share 3.87
Full Cash Flow Statement Margins Gross margin is 75.69%, with operating and profit margins of -10.47% and -14.2%.
Gross Margin 75.69% Operating Margin -10.47% Pretax Margin -9% Profit Margin -14.2% EBITDA Margin 4.15% EBIT Margin -10.47% FCF Margin 25.5%
